Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 467 entries
View as:

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03467789 Org: User:
Start: 10/01/18 End: 01/06/23 Due: 01/06/24

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00918658 Org: User:
Start: 04/30/08 End: 03/31/11 Due: 03/31/12

TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid

Phase: N/A Priority: Normal
NCT ID: NCT03397173 Org: User:
Start: 03/16/18 End: 01/21/21 Due: 01/21/22

Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00068523 Org: User:
Start: 06/30/03 End: - Due: -

Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01158521 Org: User:
Start: 06/30/10 End: 01/31/16 Due: 01/31/17

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003768 Org: User:
Start: 09/30/98 End: 07/31/01 Due: 07/31/02

Changes in Muscle Tissue in Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00369460 Org: User:
Start: 01/31/06 End: 07/31/09 Due: 07/31/10

Genomic Analysis of Families With a History of Discordant Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04860453 Org: User:
Start: 11/17/20 End: 07/01/28 Due: 07/01/29

Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04205786 Org: User:
Start: 08/12/21 End: 12/01/25 Due: 12/01/26

The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT03057613 Org: User:
Start: 05/10/17 End: 09/09/20 Due: 09/09/21

Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00021151 Org: User:
Start: 01/31/00 End: 05/31/02 Due: 05/31/03

Music Therapy and Hematopoietic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03378089 Org: User:
Start: 02/26/18 End: 06/21/19 Due: 06/21/20

PSA TOOL for Prostate Cancer Screening Discussions

Phase: N/A Priority: Normal
NCT ID: NCT03135444 Org: User:
Start: 05/02/17 End: 04/23/18 Due: 04/23/19

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01118351 Org: User:
Start: 10/31/08 End: 09/30/15 Due: 09/30/16

Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00460031 Org: User:
Start: 09/01/06 End: 08/31/10 Due: 08/31/11

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02388932 Org: User:
Start: 03/03/15 End: 02/06/17 Due: 02/06/18

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00274820 Org: User:
Start: 10/31/05 End: 10/31/07 Due: 10/31/08

Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00244309 Org: User:
Start: 11/30/05 End: 06/30/06 Due: 06/30/07

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00006465 Org: User:
Start: 12/31/00 End: 04/30/05 Due: 04/30/06

Improving Sexual Health in Gynecologic Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03827993 Org: User:
Start: 07/22/19 End: 06/15/22 Due: 06/15/23

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02307474 Org: User:
Start: 09/30/15 End: 09/30/15 Due: 09/30/16

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT06687603 Org: User:
Start: 03/10/25 End: 09/27/29 Due: 09/27/30

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00509093 Org: User:
Start: 10/31/08 End: 04/09/15 Due: 04/09/16

Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)

Phase: N/A Priority: Normal
NCT ID: NCT03086395 Org: User:
Start: 04/01/17 End: 01/01/21 Due: 01/01/22

Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03121352 Org: User:
Start: 05/19/17 End: 05/23/22 Due: 05/23/23